Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
07/14/2009 | US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors |
07/14/2009 | US7560464 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease |
07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
07/14/2009 | US7560462 Compounds useful for inhibiting CHK1 |
07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
07/14/2009 | CA2532818C (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
07/14/2009 | CA2403321C Amide compounds and use thereof |
07/14/2009 | CA2379841C Biphenyl derivatives, the preparation thereof and their use as medicaments |
07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/09/2009 | WO2009086438A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
07/09/2009 | WO2009086041A1 Herbicidal pyridazinone derivatives |
07/09/2009 | WO2009085659A1 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
07/09/2009 | WO2009084737A1 Compound having activity to suppress degranulation and cytokine production and use thereof |
07/09/2009 | WO2009084614A1 Imidazole carbonyl compound |
07/09/2009 | WO2009084007A1 Pyrrole end-capped bipyridine assay powder for selective detection of zinc ions and a process for the preparation thereof |
07/09/2009 | WO2009083724A1 Processes for the preparation of thalidomide |
07/09/2009 | WO2009083559A1 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
07/09/2009 | WO2009083553A1 Azine compounds as glucokinase activators |
07/09/2009 | WO2009083526A1 Novel compounds |
07/09/2009 | WO2009083436A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
07/09/2009 | WO2009083076A1 2-benzylpyridazinone derivatives as met kinase inhibitors |
07/09/2009 | WO2009057811A3 Heterocyclic compound and pharmaceutical composition thereof |
07/09/2009 | WO2009042200A9 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
07/09/2009 | WO2009034029A3 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists |
07/09/2009 | US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
07/09/2009 | US20090176973 Thrombopoietin mimetics |
07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
07/09/2009 | US20090176843 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
07/09/2009 | US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
07/09/2009 | US20090176838 Cyclourea Compounds as Calcium Channel Blockers |
07/09/2009 | US20090176832 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
07/09/2009 | US20090176828 treating pain with minimal cardiovascular and/or sedatory activity side effects;hypertension, depression, glaucoma, elevated intraocular pressure, ischemic neuropathies, optic neuropathy, diabetic retinopathy, stroke, withdrawal symptoms, obsessive compulsive disorder, obesity, diarrhea, nasal congestion |
07/09/2009 | US20090176827 Maleate salts of (e)-n--4-(dimethylamino)-2-butenamide and crystalline forms thereof |
07/09/2009 | US20090176824 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field |
07/09/2009 | US20090176809 Raf inhibitor compounds and methods |
07/09/2009 | US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
07/09/2009 | US20090176798 New compounds III |
07/09/2009 | US20090176796 Trpv1 antagonists including amide substituent and uses thereof |
07/09/2009 | US20090176794 1h-indol-1-yl-urea compounds |
07/09/2009 | US20090176784 Anti-infective agents and uses thereof |
07/09/2009 | US20090176782 Inhibitors of tace |
07/09/2009 | US20090176781 Acetylenic Heteroaryl Compounds |
07/09/2009 | US20090176780 Nitrogenous heterocyclic compounds |
07/09/2009 | US20090176774 Compounds and methods of use |
07/09/2009 | US20090176771 Gyrase inhibitors and uses thereof |
07/09/2009 | US20090176770 e.g. 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4.5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
07/09/2009 | US20090176767 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma |
07/09/2009 | US20090176766 Imidazolidinone and imidazolidinethione derivatives |
07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
07/09/2009 | US20090176758 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
07/09/2009 | US20090176307 Compounds, Compositions and Methods |
07/09/2009 | US20090175809 Merocyanine derivatives for cosmetic use |
07/09/2009 | US20090173916 Fluorescent diketopyrrolopyrroles |
07/09/2009 | US20090172897 Styryl thiol/disulfide compound with a hydroxy(cyclo)alkylamino unit, process for lightening keratin materials using same |
07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
07/09/2009 | CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections |
07/09/2009 | CA2710946A1 Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
07/09/2009 | CA2710092A1 Pyridazinone derivatives |
07/09/2009 | CA2707520A1 Herbicidal pyridazinone derivatives |
07/09/2009 | CA2707339A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
07/08/2009 | EP2076509A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
07/08/2009 | EP2076507A2 Imatinib base, and imatinib mesylate and processes for preparation thereof |
07/08/2009 | EP2076506A2 Heterocyclic-substituted piperidines as orl-1 ligands |
07/08/2009 | EP2076500A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
07/08/2009 | EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
07/08/2009 | EP2076496A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
07/08/2009 | EP2076495A1 Quinoline derivatives with 5-ht-binding properties |
07/08/2009 | EP2076494A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
07/08/2009 | EP2076260A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
07/08/2009 | EP1843767B1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders. |
07/08/2009 | EP1664016B9 Therapeutic agents useful for treating pain |
07/08/2009 | EP1635821B1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
07/08/2009 | CN101479259A Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
07/08/2009 | CN101479258A Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
07/08/2009 | CN101479257A Pyrimidine and quinazoline derivatives |
07/08/2009 | CN101479256A 新的吡啶类似物 Novel pyridine analogues |
07/08/2009 | CN101479255A c-MET protein kinase inhibitors for the treatment of proliferative disorders |
07/08/2009 | CN101475562A Method for synthesizing lansoprazole and salt thereof |
07/08/2009 | CN101475561A Method for synthesizing pantoprazole and salt thereof |
07/08/2009 | CN101475560A New 1H-indol-1-yl-urea compounds, a process for their preparation and pharmaceutical compositions containing them |
07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
07/08/2009 | CN100509813C Hetereoaryl nitrile derivative |
07/08/2009 | CN100509807C Indazole derivative for pestide |
07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
07/08/2009 | CN100509802C Heteroaryl deravatives as PPAR activators |
07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
07/08/2009 | CN100509799C Process for synthesizing antithrombin inhibitor of non-asymmetric non-peptide kind |
07/08/2009 | CN100509798C Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |